AX-158
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AX-158, covering 2025-10-03 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis [Phase 1, Phase 2]